Benchmark：重申ImmunoPrecise Antibodies(IPA.US)评级，由Speculative Buy调整至Speculative Buy评级, 目标价由3.00美元调整至3.00美元。 ImmunoPrecise Antibodies（IPA.US ...

Investing.com — 周二，Benchmark分析师Robert Wasserman维持对Immunoprecise Antibodies Ltd. (NASDAQ: IPA )股票的"投机性买入"评级，目标价保持在$3.00。根据 InvestingPro ...

ImmunoPrecise Antibodies (NASDAQ:IPA – Get Free Report)‘s stock had its “speculative buy” rating restated by analysts at Benchmark in a research report issued on Tuesday,Benzinga reports. They ...